Of the genes tested in plasma, BCAT1, GRASP, IKZF1, IRF4, SDC2, SEPT9 and SOX21 exhibited high sensitivity (≈55% or greater) for detection of methylated ctDNA in cancer patients. This evidence concerns the gene SEPTIN9 and cancer.